Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 402

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients

Ypenburg, C., Schalij, M. J., Bleeker, G. B., Steendijk, P., Boersma, E., Dibbets-Schneider, P., Stokkel, M. P.M., van der Wall, E. E., Bax, J. J.·2006·European Heart Journal

Abstract

AIMS: At present, 20-30% of patients do not respond to cardiac resynchronization therapy (CRT). In this study, the relation between the extent of viable myocardium and scar tissue vs. response to CRT was evaluated. In addition, the presence of scar tissue in the left ventricular (LV) lead position was specifically related to response to CRT. METHODS AND RESULTS: A total of 51 consecutive patients with ischaemic heart failure and substantial LV dyssynchrony undergoing CRT were included. All patients underwent gated SPECT before CRT implantation to determine the extent of scar tissue and viable myocardium. Clinical and echocardiographic parameters were assessed at baseline and after 6 months of CRT. The results demonstrated direct relations between the response to CRT and the extent of viable myocardium and scar tissue. In addition, the 15 patients (29%) with transmural scar tissue (< 50% tracer activity) in the region of the LV pacing lead showed no improvement after 6 months of CRT. CONCLUSION: The extent of scar tissue and viable myocardium were directly related to the response to CRT. Furthermore, scar tissue in the LV pacing lead region may prohibit response to CRT. Evaluation for viability and scar tissue may be considered in the selection process for CRT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehl379

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 402

Metadata

Authors
Ypenburg, C., Schalij, M. J., Bleeker, G. B., Steendijk, P., Boersma, E., Dibbets-Schneider, P., Stokkel, M. P. M., van der Wall, E. E., & Bax, J. J.
Venue
European Heart Journal
Published
2006-06-13
Volume
28
Issue
1
Pages
33-41
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2073523821
Cited by
402
References
27
FWCI
14.44
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. https://app.cochat.ai/papers/10.1093/eurheartj/ehl379
The paper
Ypenburg, C., Schalij, M. J., Bleeker, G. B., Steendijk, P., Boersma, E., Dibbets-Schneider, P., Stokkel, M. P. M., van der Wall, E. E., & Bax, J. J. (2006). Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. European Heart Journal. https://doi.org/10.1093/eurheartj/ehl379

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.